AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

IntroductionPharmacovigilance, a critical component of the pharmaceutical industry, involves the detection, assessment, ...

Proof of concept clinical trial will evaluate leniolisib in PIDs with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytesPIDs ...

Efforts to make therapeutics from the tiny RNA molecules have been ‘in a little bit of a slump’, but that might soon change.

New study shows that the lengths of menstrual cycles, follicular phases (before egg release) and luteal phases (after ovulation) are all variable. The luteal phase is importantly more variable than ...

Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia ...

Read about a new tool that has been developed from a nurse-led study aiming to support more lung cancer patients into ...

Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women’s Hospital, a founding member of the ...

More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...

For young people living with diabetes in Quebec, adolescence and young adulthood are periods marked by a significantly higher ...

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...